Biopharma company Regeneron Pharmaceuticals is to create 200 jobs by investing €310 million in its Limerick bioprocessing campus
News

Biopharma company Regeneron Pharmaceuticals is to create 200 jobs by investing €310 million in its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus.

The company acquired the former Dell Computer facility in Limerick and achieved planning approval in April 2014 for its first IOPS site outside of the United States. When the investment was initially announced in December 2013, a €265 million investment with 300 jobs was planned for delivery by the end of 2016. With this expansion of scope, the Limerick IOPS campus will house the largest-scale bulk biologics production facility in Ireland.

With approximately 300 full-time employees, 200 contingent workers and 550 construction workers in place, recruitment is under way to bring on additional full-time, high-end specialist jobs in commercial manufacturing, process sciences, quality assurance/control and various support functions for scientists, chemists and technicians.

“With a growing portfolio of marketed medicines and an innovative pipeline rooted in cutting-edge science and technology, Regeneron is one of the fastest-growing global biopharmaceutical companies,” said Leonard S Schleifer, president and CEO of Regeneron.

“The Limerick facility will play an essential role in ensuring Regeneron delivers on our mission to consistently and repeatedly bring new medicines to patients with serious diseases.”

“The decision to create 200 new full-time roles and invest an additional €310 million in Limerick was an easy one to make because of our hiring and trades experiences over the last two years,” said Dan Van Plew, senior vice-president and general manager of IOPS at Regeneron.

Regeneron’s 400,000-sq-ft, state-of-the-art biologics production facility in Limerick is now operational with the first production line on track to enter validation before year-end 2015.

In addition to IOPS significant operations in Limerick, the company also has a growing multifunctional team in Dublin supporting its business in Europe. Its total headcount in Ireland is expected to approach 550 by the end of 2017.

http://www.engineersjournal.ie/wp-content/uploads/2015/10/Regeneron.jpghttp://www.engineersjournal.ie/wp-content/uploads/2015/10/Regeneron-300x300.jpgDavid O'RiordanNewsjobs,Limerick,pharma
Biopharma company Regeneron Pharmaceuticals is to create 200 jobs by investing €310 million in its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus. The company acquired the former Dell Computer facility in Limerick and achieved planning approval in April 2014 for its first IOPS site outside of the United...